• Spiroplasma eriocheiris Entry Mechanisms in Drosophila S2 Ce

  2026-05-19

  Wei et al. provide the first detailed characterization of how Spiroplasma eriocheiris invades Drosophila Schneider 2 (S2) cells, identifying clathrin-mediated endocytosis and macropinocytosis as key entry pathways. This work clarifies infection processes in invertebrate cell models and offers mechanistic insights relevant for infectious disease and cell biology research.

• BMX-IN-1: Redefining BMX Kinase Inhibition in Lysosomal Biol

  2026-05-19

  Explore how BMX-IN-1, a potent BMX kinase inhibitor, is driving new frontiers in lysosomal acidification research and host-pathogen interactions. This article delivers advanced insights and unique protocol considerations for cancer and infectious disease modeling.

• Wallichinine Reverses ABCB1-Mediated Multidrug Resistance in

  2026-05-18

  This study demonstrates that wallichinine, a natural compound from Piper wallichii, effectively reverses multidrug resistance (MDR) in cancer cells overexpressing the ABCB1 transporter. The findings provide mechanistic insight into how wallichinine restores chemosensitivity and offer a new direction for developing non-toxic MDR modulators from natural products.

• Metronidazole: Applied OAT3 Inhibition in Microbiota Researc

  2026-05-18

  Metronidazole (2-(2-methyl-5-nitroimidazol-1-yl)ethanol) stands apart as both a nitroimidazole antibiotic and a precise OAT3 inhibitor, enabling advanced research in drug-drug interactions and microbiota-immune modulation. This article delivers actionable workflows, troubleshooting strategies, and data-driven insights for maximizing the impact of Metronidazole in bench-based studies.

• EDI3 Inhibition Reduces Viability in HER2+ Breast Cancer Res

  2026-05-17

  Keller et al. demonstrate that targeting EDI3, a key enzyme in choline metabolism, preferentially reduces viability and tumor growth in ER-HER2+ breast cancer cells resistant to HER2-targeted therapies. Their study uncovers EDI3 as a metabolic vulnerability and potential therapeutic target in this difficult-to-treat cancer subtype.

• Ferroptotic Tumor Cells Enhance Macrophage Antigen Presentat

  2026-05-16

  Sun et al. reveal that inducing ferroptosis in tumor cells reprograms tumor-associated macrophages to boost antigen presentation, thereby amplifying the efficacy of immune checkpoint blockade therapy. By delineating the mechanistic link between ferroptosis and adaptive anti-tumor immunity, this work provides a preclinical rationale for leveraging ferroptosis inducers to potentiate cancer immunotherapy.

• YTHDF2 Inhibition Enhances Memory via m6A mRNA Stabilization

  2026-05-15

  This study demonstrates that conditional knockout of YTHDF2 in the mouse forebrain leads to reduced degradation of m6A-modified mRNAs, resulting in increased synaptic transmission and enhanced hippocampus-dependent memory. The findings clarify the mechanistic role of YTHDF2-mediated mRNA decay in activity-dependent protein synthesis and cognitive function, with significant implications for neuroepigenetic research.

• Streamlining Macrolide Antibiotic Production via 3-O-Acyltra

  2026-05-15

  This study demonstrates the targeted genetic modification of Streptomyces spiramyceticus to produce a single-component macrolide antibiotic, 400-isovalerylspiramycin I, by in-frame partial deletion of the 3-O-acyltransferase gene. The approach addresses complexity in macrolide production, offering a path toward improved antibiotic manufacturing and specificity.

• Ionomycin Calcium Salt: Unleashing Calcium Ionophore Potenti

  2026-05-14

  Ionomycin calcium salt stands apart as a precise and potent calcium ionophore for dissecting intracellular Ca2+ dynamics, apoptosis induction, and tumor inhibition. This article delivers actionable protocols, troubleshooting advice, and context from the latest research—empowering scientists to harness Ionomycin in advanced cell signaling and cancer studies.

• Stiripentol: Applied Workflows for LDH Inhibition in Researc

  2026-05-14

  Stiripentol stands out as a noncompetitive LDH inhibitor, enabling precise modulation of lactate metabolism in epilepsy and immunometabolic studies. This guide translates recent mechanistic breakthroughs into actionable protocols, troubleshooting tactics, and advanced experimental strategies.

• Annexin V-PE Apoptosis Detection Kit: Rapid Live-Cell Analys

  2026-05-13

  Experience swift, fixation-free apoptosis detection in live cells with the Annexin V-PE Apoptosis Detection Kit. This workflow-ready solution empowers researchers to quantify early apoptotic events with precision, streamlining both flow cytometry and fluorescence microscopy assays.

• Applied Metabolism Research Using the DiscoveryProbe Library

  2026-05-13

  The DiscoveryProbe Metabolism-related Compound Library empowers researchers to dissect metabolic pathways with precision and reproducibility. This article guides you through optimized workflows, troubleshooting, and advanced applications, translating recent clinical insights into actionable bench protocols.

• ATG4B Nuclear Translocation Links Energy Deficiency to DNA R

  2026-05-12

  This study uncovers a mechanistic link between energy deficiency and impaired DNA repair in acute myeloid leukemia (AML). The authors demonstrate that nuclear translocation of ATG4B under energy stress inhibits PRMT1-mediated methylation of MRE11, thereby compromising DNA repair and accelerating leukemia progression. These insights reveal a new metabolic-genomic interface relevant for cancer biology and therapeutic targeting.

• LY294002: Applied Strategies for PI3K/Akt/mTOR Pathway Inhib

  2026-05-12

  LY294002 empowers researchers with precise, reversible PI3K/Akt/mTOR inhibition, facilitating robust studies of apoptosis, autophagy, and fibrosis. This guide translates recent reference breakthroughs and workflow best practices into actionable protocols and troubleshooting insights.

• BMX-IN-1: Optimizing BMX Kinase Inhibition in Cancer & Infec

  2026-05-11

  BMX-IN-1 delivers highly selective, irreversible BMX kinase inhibition for robust cell-based studies across oncology and infectious disease models. Its nanomolar potency and proven role in modulating lysosomal acidification empower researchers to dissect complex signaling pathways and therapeutic targets with confidence.

7700 records 18/514 page Previous Next First page 上5页 1617181920 下5页 Last page